Patent Foramen Ovale Closure with the AMPLATZER PFO OCCLUDER in Patients with REcurrent Cryptogenic Stroke due to Presumed Paradoxical EmboliSm through a Patent Foramen Ovale who have Failed Conventional Drug Therapy + save

Date Added
February 1st, 2011
IRB Number
17451
Researcher
Christopher Nielsen
Keywords
Cardiovascular, Circulation, Heart
Summary

Interventional cardiology procedure using an FDA approved product to achieve closure of a patent foramen ovale for patients who have failed conventional medication therapy.

Institution
MUSC
Recruitment Contact
Debi Adams, RN
843-792-2944
adamsde@musc.edu